REGIONAL ONCOLOGY ACCELERATED RESE… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

YVONNE ALBAUGH

Phone

2053278112

Tax Period

2024-05-01 to 2025-04-30

REGIONAL ONCOLOGY ACCELERATED RESEARCH, founded in 2014, is a small nonprofit in the Diseases & Disorders sector that reported $356K in total revenue in fiscal year 2024. Revenue fell 28% from the prior year — a significant decline worth monitoring.

Mission

TO RAISE FUNDS FOR CANCER RESEARCH PROGRAMS FOR THE DEPARTMENT OF RADIATION ONCOLGY AT THE UNIVERSITY OF ALABAMA IN BIRMINGHAM, ALABAMA

Program Service Accomplishments

Program 1

Expenses: $360,000

DONATED THE JAMES BOND GALA EVENT AND OTHER DONATIONS WHICH RAISED MONEY FOR THE DEPARTMENT OF RADIATION ONCOLOGY AT UNIVERSITY OF ALABAMA IN BIRMINGHAM, ALABAMA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $449,324

Program Service Revenue $0

Investment Income $0

Other Revenue $-93,628

TOTAL REVENUE $355,696

Expense Breakdown

Grants Paid $360,000

Salaries & Benefits $0

Fundraising Expenses $6,565

Program Expenses $360,000

Other Expenses $6,803

TOTAL EXPENSES $366,803

Year-over-Year Comparison

	2024	2023	Change
Revenue	$355,696	$495,573	-0.3%
Expenses	$366,803	$504,765	-0.3%
Net Income	$-11,107	$-9,192	+0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
YVONNE ALBAUGH	TREASURER	N/A	Officer	$0	$0	$0
KIM BUNN	CORR. SECRET	N/A	Officer	$0	$0	$0
SUZETTE FISHER	RECORDING SE	N/A	Officer	$0	$0	$0
DEAN GILES	FIRST VICE P	N/A	Officer	$0	$0	$0
JULIE KIM	EVENT CHAIRM	N/A	Officer	$0	$0	$0
MONA STEVENS	PRESIDENT	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$355,696	$366,803	$18,032	$-11,107
2024	$495,573	$504,765	$29,139	$-9,192
2023	$413,523	$693,356	$38,331	$-279,833
2022	$567,367	$353,336	$318,164	$214,031
2021	$41,124	$328,223	$104,133	$-287,099
2020	$364,373	$304,520	$391,232	$59,853
2019	$293,858	$333,931	$331,379	$-40,073
2018	$349,489	$3,658	$371,452	$345,831

REGIONAL ONCOLOGY ACCELERATED RESEARCH